Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology. Its product Grafalon is used in immunosuppressive therapies for the prevention of graft- versus- host disease in stem cell transplantation, prevention and treatment of rejection in solid organ transplantation, and in treatment of aplastic anemia.